Please use this identifier to cite or link to this item: http://repositorio.unifesp.br/handle/11600/51326
Title: Plasma copeptin and metabolic dysfunction in individuals with bipolar disorder
Authors: Mansur, Rodrigo B. [UNIFESP]
Rizzo, Lucas B. [UNIFESP]
Santos, Camila M. [UNIFESP]
Asevedo, Elson [UNIFESP]
Cunha, Graccielle R. [UNIFESP]
Noto, Mariane N. [UNIFESP]
Pedrini, Mariana [UNIFESP]
Zeni-Graiff, Maiara [UNIFESP]
Cordeiro, Quirino
McIntyre, Roger S.
Brietzke, Elisa [UNIFESP]
Keywords: bipolar disorder
copeptin
insulin resistance
metabolism
vasopressin
Issue Date: 2017
Publisher: Wiley
Citation: Psychiatry And Clinical Neurosciences. Hoboken, v. 71, n. 9, p. 624-636, 2017.
Abstract: AimThis study aimed to compare plasma copeptin levels, the c-terminal of provasopressin, between individuals with bipolar disorder (BD) and healthy controls and to assess the relation between copeptin and metabolic parameters. MethodsWe measured plasma levels of copeptin in individuals with BD (n=55) and healthy controls (n=21). Information related to psychiatric/medical history, as well as to metabolic comorbidities and laboratorial parameters was also captured. Insulin resistance and -cell function in basal state were calculated from fasting plasma glucose and C-peptide using the HOMA2 calculator. Impaired glucose metabolism was defined as pre-diabetes or type 2 diabetes mellitus. Copeptin, adiponectin, and leptin plasma levels were determined by enzyme-linked immunosorbent assay. ResultsPlasma copeptin levels were lower in individuals with BD, relative to healthy controls (P<0.001). There were significant interactions between BD and plasma copeptin on -cell function (rate ratio [RR]=1.048
P=0.030) and on leptin levels (RR=1.087
P=0.012), indicating that there was a positive correlation between these markers in the BD group, but a negative one in healthy controls. Finally, in individuals with BD only, the association between -cell function, body mass index (RR=1.007
P<0.001), and insulin resistance (RR=1.001
P=0.037) was moderated by copeptin levels. ConclusionCopeptin levels were lower in individuals with BD than in healthy controls. There were differential associations between copeptin and metabolic parameters within the BD and healthy control subgroups, suggesting an association between abnormal copeptin and metabolic dysregulation only in the BD population.
URI: http://repositorio.unifesp.br/handle/11600/51326
ISSN: 1323-1316
Other Identifiers: http://dx.doi.org/10.1111/pcn.12535
Appears in Collections:Artigo

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.